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INTRODUCTION
The measurement of perfusion is very important to under-
stand the physiology at the tissue level. And local myocardial
perfusion (LMP) can identify hypoperfused myocardial tissue
more precisely. In particular, during ischemia the myocardial
layers of the left ventricle can be ischemic, while the epicardial
blood flow is preserved. Many drugs have been used to improve
the myocardial function in patients with coronary disease, and
they may affect the LMP by various mechanisms (1-5). Nicar-
dipine, a dihydropyridine calcium antagonist, is one of the
most commonly used drugs to control the high blood pressure
after coronary artery bypass graft. Nicardipine has relatively
selective coronary vascular action (6). However, there has been
no study of identifying the nicaridipine effects in myocardium
by using LMP after the coronary reperfusion.
Therefore, this study was undertaken to evaluate the nica-
dipine’s effect in myocardial layers after the coronary reperfu-
sion. The LMP and left anterior descending coronary blood
flow (BF-LAD) before and after left anterior descending coro-
nary artery (LAD) occlusion were evaluated according to the
nicardipine administration.
MATERIALS AND METHODS
This investigations were performed under a protocol approv-
ed by the Institutional Animal Investigation Committee,
Keimyung University, Daegu, Korea. A total of 14 mongrel
dogs, weighing 20-25 kg, were entered into the study. We
divided the dogs into two groups, control group (n=7) and
nicardipine group (n=7). The anesthesia was induced by 20
mg/kg thiopental sodium and 0.2 mg/kg vecuronium bromide
followed by tracheal intubation after 2 min. Mechanical ven-
tilation was done with 50% nitrous oxide in oxygen and 1-1.5
vol% isoflurane with a tidal volume of 15 mL/kg with a res-
piratory rate of 12/min. 
A left thoracotomy was performed on the 5th or 6th inter-
costal space and LAD was exposed for occlusion and release.
A thermal diffusion microprobe (TDM) was implanted in the
myocardium perfused by the exposed LAD. To prevent the
TDM displacement during cardiac contraction, the TDM was
sutured in place. The TDM was then connected to QFlow
TM
400 perfusion measurement system (Thermal technologies
Inc., Cambridge, MA, U.S.A.) to measure LMP. The proximal
LAD was dissected and the Doppler probe (HT107 medical
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Nicardipine Augments Local Myocardial Perfusion after Coronary
Artery Reperfusion in Dogs
Nicardipine is a potent coronary and systemic vasodilator without depression of
ventricular function. We investigated the changes in local myocardial perfusion
(LMP) according to the nicardipine administration after coronary reperfusion in a
beating canine model. A Doppler probe was placed around the left anterior descend-
ing coronary artery (LAD) and thermal diffusion microprobe was implanted in the
myocardium perfused by the exposed LAD. To define the nicardipine effects, we
compared the two groups (control group, n=7 vs nicardipine group, n=7). In nicardip-
ine group, 5  g/kg/min nicardipine was infused continuously. After the release of
the LAD occlusion, LAD blood flow were increased compared to the baseline of
both groups. However, there was no difference between groups in the LAD
blood flow. The LMP after LAD reperfusion did not recover to the baseline level
until 30 min after LAD reperfusion in control group (74%, 52% and 70% at 10, 20
and 30 min after LAD reperfusion, respectively). In nicardipine group, however, the
LMP recovered to the baseline level at 20 min (99%), and increased more than
the baseline level at 30 min (141%) after LAD reperfusion. Our findings suggest
that the nicardipine augments the LMP following the release of a coronary occlu-
sion.
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volume flowmeter, Transonic systems Inc., Ithaca, NY,
U.S.A.) for measuring BF-LAD were placed around the LAD
(Fig. 1). 
After a sufficient stabilization period (30-60 min after sur-
gical preparation), baseline LMP and BF-LAD were measured.
The exposed coronary artery just proximal to the doppler probe
was then occluded with an atraumatic clip for a period of 20
min, and all data were measured. We identified the appropri-
ate TDM location by dusky region after LAD occlusion and
by k-value. The k-value or tissue conductivity should not exce-
ed 6.23 m ∙ W/cm/℃ in this system. The k-value exceed-
ing 6.23 m ∙ W/cm/℃ indicates inappropriate microprobe
positioning or other artifacts. 
And then, LAD was reperfused following clip removal. In
nicardipine group, 5  g/kg/min nicardipine (Yamanouchi
Co., Ltd. 1 mg/mL in 0.9% NaCl solution, Japan) was infused
continuously, immediately before LAD reperfusion. The LMP
and BF-LAD were also measured at 10, 20 and 30 min after
the LAD reperfusion, repeatedly. 
All data were presented as mean±SD. Comparisons bet-
ween groups were performed by repeated measures ANOVA
with SPSS program (version 10.0). Probability values < 0.05
were considered significant. 
RESULTS
BF-LAD and LMP in two groups are presented in Table 1.
The baseline BF-LAD in control group and nicardipine group
were 17.5±6.7 mL/min and 18.4±7.3 mL/min, respective-
ly. The BF-LAD decreased to 0 mL/min after LAD occlu-
sion in both groups. Ten min after the coronary reperfusion,
the BF-LAD were 66.2±13.4 mL/min in control group,
and 64.5±11.6 mL/min in nicardipine group, respectively.
And then, the BF-LAD at 20 and 30 min after the coronary
reperfusion decreased, but did not return to the baseline level
until 30 min after the coronary reperfusion. There was no sta-
tistical difference in BF-LAD between the two groups. 
The baseline LMP in control group and nicardipine group
were 52.0±18.3 mL/100 g/min and 49.6±2.9 mL/100
g/min, respectively. After the LAD occlusion, the LMP de-
creased to 18.4±17.0 mL/100 g/min in control group and
23.4±4.0 mL/100 g/min in nicardipine group. At the
immediate reperfusion period, the LMP abruptly increased
up to the 200-250 mL/100 g/min (the maximum range of
QFlow
TM400 system is 250 mL/100 g/min) in both groups
for 3 to 5 min after the LAD reperfusion. In nicardipine group,
the LMP increased to the baseline level at 20 min after LAD
reperfusion (49.1±7.9 mL/100 g/min) and increased more
than the baseline value at 30 min after the LAD reperfusion
(70.0±7.1 mL/100 g/min). In control group, however, the
LMP did not recover to the baseline level at 20 and 30 min
after the LAD reperfusion (27.2±17.4 mL/100 g/min and
36.2±17.2 mL/100 g/min at 20 and 30 min after LAD
reperfusion, respectively). 
Blood flow (mL/min)
Control 17.5±6.7 0 66.2±35.8* 35.8±9.3* 25.5±6.7*
Nicardipine    18.4±7.3 0  64.5±11.6* 30.4±8.7* 24.9±5.8*
LMP (mL/100 g/min)       
Control 52.0±18.3 18.4±17.0* 38.5±23.2 27.2±17.4* 36.2±17.2*
Nicardipine 9.6±2.9 23.4±4.0* 30.6±5.3* 49.1±7.9
� 70.0±7.1*
,�
Baseline  LAD occlusion
Table 1. Changes in left anterior descending coronary artery blood flow and local myocardial perfusion according to the LAD reper-
fusion in dogs
Values are mean±SD. LMP: local myocardial perfusion; LAD: left anterior descending coronary artery; There was no statistically difference in blood
flow change between two groups. *Significantly different from baseline; 
�Significantly different from control at each time.
Time after LAD reperfusion (min)
10 20 30
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DISCUSSION
The most important determinant of tissue oxygenation and
substrate delivery is tissue perfusion. The measurement of
tissue perfusion, therefore, is a key point to understand both
normal and pathologic physiology. Many techniques, such as
laser-Doppler flowmetry, radioactive microsphere technique,
have been used to measure tissue blood flow (7-9). Previous
methods, however, have been inefficient to measure local tissue
perfusion (10, 11). In this study, we used TDM to measure
LMP distal to the LAD, which validated many other organs
(11-14).
Nicardipine has many properties of an ideal drug to control
postoperative hypertension (15). The drug has a direct effect
on vascular smooth muscle cells, and it causes vasodilation and
reduction of blood pressure (16). Nicardipine also has the myo-
cardial protective effect, and reduces the severity of myocar-
dial ischemia (17). Nicardipine is a potent coronary and sys-
temic vasodilator without evidence of depression of ventric-
ular function. Therefore, we postulated that the nicardipine
administration during coronary artery reperfusion may aug-
ment the LMP. In this study, the LMP after LAD occlusion
were maintained to 35% and 48% of the baseline level in con-
trol group and nicardipine group, respectively. This phenome-
non may suggest that other conduit coronary arteries, such as
right coronary and circumflex artery, can normally supply some
blood to LAD distributed myocardial area during the LAD
occlusion. After immediate LAD reperfusion, we could find
the hyperemic state in LMP. The duration of this state was
about 3-5 min. One interesting result is that the LMP did
not recover to the baseline level despite of BF-LAD increase
after LAD reperfusion in control group. This phenomenon
shows that impaired myocardial microcirculation occurs after
coronary reperfusion in normal condition. Many substances
such as free radical, cytokine, prostaglandins, and other pep-
tides may play roles in this phenomenon (10). It is hence believ-
ed that the LMP is more reliable parameter than blood flow
in ischemia or reperfusion state. This may suggest that it is
not enough to measure blood flow in a coronary artery when
trying to assess the adequacy of myocardial perfusion. 
In nicardipine group, the LMP recovered to the baseline
level at 20 min (99%) after LAD reperfusion and increased
more than the baseline level at 30 min (141%) after LAD
reperfusion. This result indicates that the nicardipine has an
effect of LMP augmentation during the coronary reperfusion
period. 
We found that the LMP did not recover despite the increase
of BF-LAD after coronary artery reperfusion in control group.
However, the LMP can increase by using nicardipine during
the coronary reperfusion period. In conclusion, nicardipine
improves myocardial tissue perfusion following the release of
a coronary occlusion in dogs. 
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